Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06918132RecruitingPhase 2
Cemiplimab and Fianlimab before lung cancer surgery
This trial tests whether two immunotherapy drugs (cemiplimab and fianlimab) given before surgery can help treat stage IB to IIIB non-small cell lung cancer. You must have a PD-L1 level of at least 1% and your surgeon must think the tumor can be fully removed.
Rochester, MinnesotaAges 18 years+ - NCT06915597Recruiting
Drug-coated balloons for coronary artery disease
This trial is studying how well drug-coated balloons work for people with coronary artery disease. It looks at their use in many different situations, including new blockages, re-narrowed stents, and complex cases. The goal is to see if they are a good option for opening blocked arteries.
DenizliAges 18 years+ - NCT06911723Recruiting
Testing a mood-changing activity for people with psychosis and healthy volunteers
This study tests whether a mood-changing activity works for people with psychotic disorders (like schizophrenia) and healthy volunteers. It aims to see if it's acceptable and helpful.
Birmingham, AlabamaAges 18–65 - NCT06916481Recruiting
Pneumonia subtypes based on lung bacteria
This study looks at the germs in your lungs to understand why some people's pneumonia doesn't get better with standard antibiotics. If you are hospitalized with pneumonia and have just started treatment, you may be asked to provide a sputum sample so researchers can study your lung microbiome.
ClichyAges 18 years+ - NCT06423664Recruiting
Study on child development after cannabis use in pregnancy
This study looks at how cannabis (marijuana) use during pregnancy might affect a child's development. If you used cannabis while pregnant and gave birth to a healthy baby at full term, you and your child may be able to join.
Albuquerque, New MexicoAges Up to 1 week - NCT06135350RecruitingPhase 2
Preventing infections in ICU patients on ventilators
This trial tests an experimental drug called Fluorothiazinone to prevent serious bacterial infections in ICU patients who are on a breathing machine (ventilator) or likely to need one soon. It includes patients with COVID-19 pneumonia, stroke, or heart failure.
Moscow, MoscowAges 18 years+ - NCT06911437Enrolling by invitation
Knee pain relief with Chinese formula and massage
This study tests if combining a Chinese herbal formula called Xiaoyu Zhitong with a gentle drainage massage can reduce knee pain and swelling. It may help people whose knee symptoms are worse in cold, damp weather.
BeijingAges 25–70 - NCT06907615RecruitingPhase 2
Study of HLX43 for advanced non-small cell lung cancer
This trial tests a new drug, HLX43, for people with advanced non-small cell lung cancer that has not responded to standard treatments. It aims to see if HLX43 can help shrink or control the cancer.
Houston, TexasAges 18 years+ - NCT06909214RecruitingPhase 4
Study of efgartigimod for new-onset generalized myasthenia gravis
This study tests a new treatment called efgartigimod for people who have been recently diagnosed with generalized myasthenia gravis (gMG). It aims to see if this medicine can help manage symptoms like muscle weakness.
La Jolla, CaliforniaAges 18 years+ - NCT06902584Recruiting
Comfilcon A contact lens study for current wearers
This study is for people who currently wear Comfilcon A contact lenses (including sphere, toric, multifocal, toric multifocal, or Energys) and have used them for at least a year. It also requires that you sometimes sleep in your lenses. The purpose is to gather ongoing information about these lenses.
Berkeley, CaliforniaAges 8–75 - NCT04677907Recruiting
Testing a metal knee implant feature in osteoarthritis surgery
This trial studies a specific type of knee replacement and how well it works after surgery for people with knee osteoarthritis. It may help doctors understand which implant approach leads to better outcomes and recovery.
Glasgow, ScotlandAges 18 years+ - NCT06186037RecruitingPhase 4
Lower-dose combo vs. higher-dose alone for heart artery disease
This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.
Suwon, Gyeonggi-doAges 19 years+ - NCT06153121Recruiting
Arm and shoulder tests for healthy tennis players and swimmers
This study is for healthy tennis players and swimmers. It tests a set of physical performance tests for the upper body (arms, shoulders, hands) to see how well they measure athletic ability. If you are a competitive tennis player or swimmer and have no arm or shoulder problems, you may be eligible.
GhentAges 12–40 - NCT06588426Recruiting
Skin punch biopsy collection for heart disease research
This trial collects a small skin sample (like a biopsy) from people with congenital heart disease. The samples help prepare for future clinical trials that may test new heart treatments.
Rochester, MinnesotaAges 18 years+ - NCT06909682Recruiting
AI monitoring with wearables for chronic heart failure
This trial tests an AI system that uses wearable devices and mini-invasive tools to monitor people with chronic heart failure. The goal is to detect changes early and help manage the condition at home.
SalernoAges 19 years+ - NCT06909240Recruiting
Walking training after first leg blood clot: a study
This study tests whether a progressive walking program helps people recover better after their first leg blood clot (DVT). You would be part of a walking training group and researchers will see if it improves walking ability and leg symptoms.
Hvidovre, Capital RegionAges 18 years+ - NCT06904027Recruiting
Glycerol phenylbutyrate for children with urea cycle disorders
This trial tests a medicine called glycerol phenylbutyrate in children with urea cycle disorders, which are genetic conditions that make it hard for the body to get rid of extra ammonia. The goal is to see if the medicine can help lower ammonia levels and manage the condition safely.
Beijing, Beijing MunicipalityAges birth–18 years - NCT06908473Enrolling by invitationPhase 3
Tongmai Jiangtang capsule for heart risks in metabolic syndrome
This trial tests whether the Tongmai Jiangtang capsule can reduce serious heart and stroke problems in older adults with metabolic syndrome who are also at high risk for heart disease. It focuses on people with a specific traditional Chinese medicine pattern called Qi-deficiency and Blood Stasis.
Guangzhou, GuangdongAges 65 years+ - NCT06903078Recruiting
Shingles and Dementia Risk Study
This study looks at whether the virus that causes shingles (herpes zoster) might increase the risk of dementia. Participants with a fresh shingles rash will give blood samples and attend several follow-up visits over one year.
Houston, TexasAges 18 years+ - NCT06910293Recruiting
Brain Activity During Menstrual Cycle vs. Fertility Treatment
This study looks at how natural menstrual cycles and ovarian stimulation (which mimics some fertility treatments) affect brain activity and hormone levels. Researchers want to understand normal brain changes during the cycle to help improve fertility treatments.
Abu Dhabi, Abu Dhabi EmirateAges 25–35 - NCT06902389RecruitingPhase 1/Phase 2
Multi-target immune cell therapy for advanced liver cancer
This trial tests a new type of immune cell therapy (multi-target Hi-TCR-T cells) for people with advanced liver cancer that hasn't responded to earlier treatments. The therapy targets several markers on your cancer cells to try to attack the tumor more effectively.
Shanghai, Yangpu DistrictAges 18–75 - NCT06911008RecruitingPhase 1
Study of a new drug for advanced solid tumors
This study tests an experimental drug called MTI-301 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug can shrink tumors or slow their growth, and to check its safety.
Jacksonville, FloridaAges 18 years+ - NCT06905054RecruitingPhase 2
Preventing PSC recurrence after liver transplant
This trial tests whether fenofibrate can prevent primary sclerosing cholangitis (PSC) from coming back after a liver transplant. It is for adults who had a liver transplant for PSC between 1 and 7 years ago and have certain risk factors.
Scottsdale, ArizonaAges 18–75 - NCT06905002Recruiting
Improving access to cancer clinical trials
This study tests whether a nurse navigator can help more people learn about and enroll in cancer clinical trials. It focuses on patients and health care professionals in Thunder Bay and Winnipeg.
Thunder Bay, OntarioAges Any age
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.